We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 1,051

U.S. House legislation highlights escalating government-wide focus on opioid abuse
  • Hogan Lovells
  • USA
  • July 6 2018

On June 22 the U.S. House of Representatives passed sweeping legislation that represents "the biggest effort Congress has ever undertaken" to address


Washington Healthcare Update - Jul 2, 2018
  • McGuireWoods LLP
  • USA
  • July 2 2018

House GOP appropriators have again postponed consideration of their Labor-HHS-Education spending bill. The markup, which had been rescheduled for


Washington Healthcare Update - Jun 18, 2018
  • McGuireWoods LLP
  • USA
  • June 18 2018

The House began its two-week vote-a-thon on opioid legislation. On June 12, the house passed 25 bills and continued to work on opioid legislation


Connecticut and Maine Become the Latest States to Adopt New Drug Pricing Transparency Laws
  • Arent Fox LLP
  • USA
  • June 6 2018

Connecticut and Maine recently joined the increasing number of states to enact drug price transparency laws. Maine’s drug price transparency law (the


Capitol Hill Healthcare Update
  • Baker & Hostetler LLP
  • USA
  • May 21 2018

House Speaker Paul Ryan, R-Wis., last week said congressional leaders are trying to hammer out compromise legislation that would make it easier for


Washington Healthcare Update - May 21, 2018
  • McGuireWoods LLP
  • USA
  • May 21 2018

On May 17, the Energy and Commerce Committee held the second of its opioid legislation markups, clearing 32 bills. The previous markup reported out 25


A Look Inside Trump's 4-Point Plan For Curbing Drug Prices
  • Ropes & Gray LLP
  • USA
  • May 18 2018

On May 11, President Donald Trump outlined his administration’s four-point plan for curbing prescription drug prices. With rare exceptions, the plan


Capitol Hill Healthcare Update
  • Baker & Hostetler LLP
  • USA
  • May 14 2018

On Capitol Hill, reaction to President Donald Trump’s “American Patients First” plan to bring down prescription drug prices fell predictably along


Washington Healthcare Update - May 14, 2018
  • McGuireWoods LLP
  • USA
  • May 14 2018

The House announced its rescission package following a “message” from the White House about what programs it wanted to cut. Initially, President Trump


Administration Releases Long-Awaited Drug Pricing Reform Plan
  • Cooley LLP
  • USA
  • May 11 2018

Today, the President and Health and Human Services (HHS) Secretary Alex Azar unveiled a 44-page Blueprint to Lower Drug Prices and Reduce